Literature DB >> 33407209

Mild hyponatremia is associated with low skeletal muscle mass, physical function impairment, and depressive mood in the elderly.

Chisato Fujisawa1,2,3, Hiroyuki Umegaki4, Taiki Sugimoto5, Satoshi Samizo4, Chi Hsien Huang4, Haruki Fujisawa6, Yoshihisa Sugimura6, Masafumi Kuzuya4, Kenji Toba5, Takashi Sakurai4,5.   

Abstract

BACKGROUND: Mild hyponatremia (serum sodium 130-135 mEq/L) is a common electrolyte disorder in the elderly. However, its association with both sarcopenia and cognitive function remains to be clarified. Therefore, here we investigated the association of mild hyponatremia with skeletal muscle mass, physical function, and cognitive function in the elderly.
METHODS: We enrolled 75 participants with mild hyponatremia and 2907 with normonatremia (serum sodium, 136-145 mEq/L) aged ≥70 years who visited the Memory Disorder Outpatient Center of Japan's National Center for Geriatrics and Gerontology. Skeletal muscle mass index (SMI), grip strength (GS), walking speed (WS), one-leg standing (OLS) test times, and neuropsychological test scores were determined.
RESULTS: One-way analysis of covariance showed that elderly participants with mild hyponatremia had lower SMI (7.1 ± 0.2, 7.2 ± 0.2 kg/m2, p = 0.04), weaker GS (19.1 ± 1.9 vs 21.4 ± 1.8 kg, p = 0.01), slower WS (0.9 ± 0.1 vs 1.1 ± 0.1 m/s, p = 0.001), and higher GDS- 15 score (6.4 ± 0.9 vs 5.2 ± 0.9, p = 0.002) than those with normonatremia. Multiple logistic regression analysis indicated that mild hyponatremia was independently associated with sarcopenia (odds ratio [OR]: 2.2, p = 0.02), slower WS (OR: 5.3, p = 0.04) and shorter OLS time (OR: 2.5, p = 0.02) as well as with severe depressive mood (OR: 2.6 p = 0.006) but not with SMI (OR: 1.6, p = 0.2) or GS (OR: 1.9, p = 0.09).
CONCLUSIONS: Our results suggest that elderly people with even mild hyponatremia had physical function impairment and depressive mood.

Entities:  

Keywords:  Balance impairment; Depression; Electrolyte disorder; Gait instability; Grip strength; Hyponatremia

Mesh:

Year:  2021        PMID: 33407209      PMCID: PMC7788730          DOI: 10.1186/s12877-020-01955-4

Source DB:  PubMed          Journal:  BMC Geriatr        ISSN: 1471-2318            Impact factor:   3.921


  30 in total

1.  Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.

Authors:  Vladimir Coric; Snezana Milanovic; Suzanne Wasylink; Pinal Patel; Robert Malison; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2003-03-26       Impact factor: 4.530

2.  Diagnostic performance of the Chinese Frontal Assessment Battery in early cognitive impairment in an Asian population.

Authors:  M S Chong; W S Lim; S P Chan; L Feng; M Niti; P Yap; D Yeo; T-P Ng
Journal:  Dement Geriatr Cogn Disord       Date:  2011-01-20       Impact factor: 2.959

3.  Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment.

Authors:  M C Mauri; A Ferrara; L Boscati; S Bravin; F Zamberlan; M Alecci; G Invernizzi
Journal:  Neuropsychobiology       Date:  1998       Impact factor: 2.328

4.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.

Authors:  Liang-Kung Chen; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Ming-Yueh Chou; Katsuya Iijima; Hak Chul Jang; Lin Kang; Miji Kim; Sunyoung Kim; Taro Kojima; Masafumi Kuzuya; Jenny S W Lee; Sang Yoon Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Jae-Young Lim; Wee Shiong Lim; Li-Ning Peng; Ken Sugimoto; Tomoki Tanaka; Chang Won Won; Minoru Yamada; Teimei Zhang; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2020-02-04       Impact factor: 4.669

5.  Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease.

Authors:  K W Kim; D Y Lee; J H Jhoo; J C Youn; Y J Suh; Y H Jun; E H Seo; J I Woo
Journal:  Dement Geriatr Cogn Disord       Date:  2005-03-22       Impact factor: 2.959

6.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

7.  Physical Function Differences Between the Stages From Normal Cognition to Moderate Alzheimer Disease.

Authors:  Chisato Fujisawa; Hiroyuki Umegaki; Kazushi Okamoto; Hirotaka Nakashima; Masafumi Kuzuya; Kenji Toba; Takashi Sakurai
Journal:  J Am Med Dir Assoc       Date:  2017-02-22       Impact factor: 4.669

Review 8.  Is asymptomatic hyponatremia really asymptomatic?

Authors:  Guy Decaux
Journal:  Am J Med       Date:  2006-07       Impact factor: 4.965

9.  Intracellular levels of glutamate in swollen astrocytes are preserved via neurotransmitter reuptake and de novo synthesis: implications for hyponatremia.

Authors:  Alexandra L Schober; Alexander A Mongin
Journal:  J Neurochem       Date:  2015-08-03       Impact factor: 5.372

10.  Impact of hyponatremia on nerve conduction and muscle strength.

Authors:  Frédéric Vandergheynst; Yannick Gombeir; Flavio Bellante; Gaetano Perrotta; Gauthier Remiche; Christian Mélot; Nicolas Mavroudakis; Guy Decaux
Journal:  Eur J Clin Invest       Date:  2016-02-23       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.